High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture

Vaccine

Volumn 25, Issue 1, 2007, Pages 19-24

  Liu, Chia Chyi ^a   Lian, Wei Cheng ^b   Butler, Michael ^c   Wu, Suh Chin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Enterovirus 71; Microcarrier; Serum free culture; Vaccine

Indexed keywords

INACTIVATED VACCINE; VIRUS RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; ENTEROVIRUS 71; IMMUNIZATION; IMMUNOGENICITY; MICROCARRIER CULTURE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TITRATION;

AMINO ACID SEQUENCE; ANIMALS; BIOREACTORS; CERCOPITHECUS AETHIOPS; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; MICE; MICE, INBRED ICR; MICROSPHERES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; SERUM; VACCINES, INACTIVATED; VERO CELLS; VIRAL PROTEINS; VIRAL VACCINES; VIRUS CULTIVATION;

EID: 33845205522     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.083     Document Type: Article

References (20)

1. Schmidt N.J., Lennette E.H., and Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129 (1974) 304-309
2. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26 (2002) 91-107
3. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., et al. The enterovirus type 71 epidemic of Taiwan in 1998. N Eng J Med 341 (1999) 929-935
4. Wang J.R., Tuan Y.C., Tsai H.P., Yan J.J., Liu C.C., and Su I.J. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 40 (2002) 10-15
5. Lin T.Y., Twu S.J., Ho M.S., Chang L.Y., and Lee C.Y. Enterovirus 71 outbreaks. Taiwan: occurrence and recognition. Emerg Infect Dis 9 (2003) 291-293
6. Shimizu H., Utama A., Onnimala N., Li C., Li-Bi Z., Yu-Jie M., et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific region. Pediatr Int 46 2 (2004) 231-235
7. Brown B.A., Oberste M.S., Alexander Jr. J.P., Kennett M.L., and Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73 12 (1999) 9969-9975
8. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., and Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 (2002) 895-904
9. Montagnon B.J. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line. Dev Biol Standard 70 (1989) 27-47
10. Mendonca R.Z., Ioshimoto L.M., Mendonca R.M., De-Franco M., Valentini E.J., Becak W., et al. Preparation of human rabies vaccine in Vero cell culture using a microcarrier system. Braz J Med Biol Res 26 12 (1993) 1305-1317
11. Aunins J.G. Viral vaccine production in cell culture. In: Spier R.E. (Ed). Encyclopedia of cell technology vol 2 (2000), John Wiley & Sons 1182-1217
12. Van Wezel A.L. Growth of cell strain and primary cells on microcarriers in homogeneous culture. Nature 216 (1967) 64-65
13. Henzler H.J., and Kaiser K. Avoiding viral contamination in biotechnological and pharmaceutical processes. Nat Biotechnol 16 11 (1998) 1077-1079
14. WHO. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological susbstances no. 50). Biological 26 3 (1998) 175-193
15. Merten O.W., Wu R., Couvé E., and Crainic R. Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors. Cytotechnology 25 (1997) 35-44
16. Butler M., Burgener A., Patrick M., Berry M., Moffatt D., Huzel N., et al. Application of a serum-free medium for the growth of Vero cells and the production or reovirus. Biotechnol Prog 16 (2000) 854-858
17. Wu S.C., and Huang G.Y.L. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus. Biotechnol Prog 18 (2002) 124-128
18. Frazatti-Gallina N.M., Mourao-Fuches R.M., Paoli R.L., Silva M.L., Miyaki C., Valentini E.J., et al. Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23 4 (2004) 511-517
19. Wu S.C., Liu C.C., and Lian W.C. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22 29-30 (2004) 3858-3864
20. Ranganathan S., Singh S., Poh C.L., and Chow V.T. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Appl Bioinform 1 1 (2002) 43-52